Koers Green Growth Brands Inc Canadian Securities Exchange
Aandelen
CA98401B2030
Farmaceutische producten
Omzet 2018 | - | Omzet 2019 | 15,73 21,51 14,43 | Marktkapitalisatie | 422 mln. 577 mln. 387 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -6 mln. -8,2 mln. -5,5 mln. | Nettowinst (verlies) 2019 | -64 mln. -87,5 mln. -58,71 mln. | EV/omzet 2018 * | - |
Nettoliquiditeiten 2018 | 4,69 mln. 6,41 mln. 4,3 mln. | Nettoschuld 2019 | 77,13 mln. 105 mln. 70,75 mln. | EV/omzet 2019 | 31.748.758 x |
K/w-verhouding 2018 * |
-
| K/w-verhouding 2019 |
-5,47
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 78,55% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,94% | 4,99 mld. | |
-32,21% | 3,61 mld. | |
-1,43% | 3,1 mld. | |
-25,09% | 2,64 mld. | |
-11,46% | 2,32 mld. | |
+36,65% | 1,85 mld. | |
+37,15% | 1,43 mld. | |
-16,01% | 1,39 mld. | |
+40,95% | 1,37 mld. |